Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial.
Wedege
E
E
National Institute of Public Health, Oslo.
Bjune
G
G
Frøholm
L O
LO
Høiby
E A
EA
Rosenqvist
E
E
D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology*; D000917:Antibody Formation; D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting / Q000379:methods / Q000592:standards*; D022401:Meningococcal Vaccines; D009664:Norway; D011135:Polysaccharides, Bacterial / Q000276:immunology*
D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B